JAMJOOM PHARMACEUTICALS FACTORY CO. financial statements, including revenue, expenses, profit, and loss
The total revenue of 4015 for the last quarter is 327.58 M SAR, and it's 5.25% lower compared to the previous quarter. The net income of Q3 24 is 94.99 M SAR.